Bhaskar Chaudhuri
CIK: 0001458643
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
3.8K shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
2.4K shares- - Jun 12, 2026TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct3K shares- - Jun 13, 2025TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct3.4K shares- - Jun 12, 2025ARQT
Arcutis Biotherapeutics, Inc.
Award(A)Direct7.6K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
4.5K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 3,837 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 2,417 | - | - | Direct |
| Jun 12, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 2,954 | - | $0 | Direct |
| Jun 13, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 3,350 | - | - | Direct |
| Jun 12, 2025 |  ARQT Arcutis Biotherapeutics, Inc. | Award(A) | 7,609 | - | - | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 4,540 | - | - | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 2,954 | - | - | Direct |
1-7 of 7 transactions
About CHAUDHURI BHASKAR
CHAUDHURI BHASKAR (SEC CIK 0001458643) files insider reports with the SEC as Director of Tarsus Pharmaceuticals, Inc. (TARS) and Director of Arcutis Biotherapeutics, Inc. (ARQT).
Signal8 holds 4 ownership filings by CHAUDHURI BHASKAR, all Form 4s, filed between Jun 16, 2025 and Jun 29, 2026. Those filings report 7 transactions, from Jun 12, 2025 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CHAUDHURI BHASKAR's filings is in IRVINE, CA.
Recent filings by CHAUDHURI BHASKAR
- Jun 25, 2026: Grants or awards of TARS derivative securities (2 lines, Form 4, code A).
- Jun 12, 2026: Option exercise of TARS shares (Form 4, code M).
- Jun 13, 2025: Option exercise of TARS shares (Form 4, code M).
- Jun 12, 2025: Grant or award of ARQT shares (Form 4, code A).
- Jun 12, 2025: Grants or awards of TARS derivative securities (2 lines, Form 4, code A).
Other insiders filing for Tarsus Pharmaceuticals, Inc. (TARS)
- PYOTT DAVID E I, Director
- YARNO WENDY L, Director
- LINK WILLIAM J PHD, Director
- Azamian Bobak R., President/CEO and Board Chair
- Lin Elizabeth Yeu, Chief Medical Officer
- Neervannan Seshadri, Chief Operating Officer